Am J Epidemiol. 2022 Jul 23;191(8):1343-1346. doi: 10.1093/aje/kwac073.
A recent study by Wesselink et al. (Am J Epidemiol. 2022;191(8):1383-1395) adds to the growing body of research finding that vaccination for coronavirus disease 2019 (COVID-19) is safe for individuals either seeking pregnancy or who are pregnant. The study's authors found no effect of COVID-19 vaccination on fecundity in a population of individuals with no known infertility who were attempting conception. The finding reinforces the messaging of the American Society for Reproductive Medicine COVID-19 Task Force, the aim of which is to provide data-driven recommendations to individuals contemplating pregnancy in the face of the COVID-19 pandemic. As safe and effective COVID-19 vaccines became available, and with an increasing number of studies showing a heightened risk of severe disease during pregnancy, an important role of the Task Force is to encourage vaccination during the preconceptual window and in early pregnancy. The Task Force supports ongoing research to address gaps in knowledge about safe and effective therapies and preventive measures for individuals contemplating pregnancy and during pregnancy. Such research will help optimize care for reproductive-age individuals in the face of current and future health crises.
最近，Wesselink 等人的研究（Am J Epidemiol. 2022;191(8):1383-1395）增加了越来越多的研究结果，这些研究发现，对于寻求怀孕或已经怀孕的个人，接种 2019 年冠状病毒病（COVID-19）疫苗是安全的。研究作者在试图怀孕的无已知不孕个体人群中发现 COVID-19 疫苗接种对生育力没有影响。这一发现强化了美国生殖医学学会 COVID-19 工作组的信息传递，该工作组的目的是在 COVID-19 大流行期间为考虑怀孕的个人提供数据驱动的建议。随着安全有效的 COVID-19 疫苗的出现，以及越来越多的研究表明怀孕期间患重病的风险增加，工作组的一个重要作用是鼓励在孕前和孕早期接种疫苗。工作组支持正在进行的研究，以解决有关考虑怀孕和怀孕期间个体的安全有效治疗和预防措施的知识空白。此类研究将有助于在当前和未来的健康危机中为育龄个人提供最佳护理。
